Fangyuan Hu

1.1k total citations
40 papers, 765 citations indexed

About

Fangyuan Hu is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fangyuan Hu has authored 40 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fangyuan Hu's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Fangyuan Hu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (5 papers) and T-cell and B-cell Immunology (5 papers). Fangyuan Hu collaborates with scholars based in China, United States and Sweden. Fangyuan Hu's co-authors include Yinghong Zhai, Xiaofei Ye, Jinfang Xu, Badi El Osta, Jia He, Xiaojing Guo, Shou Ching Tang, Qin Luo, Wenxin Qin and Cun Wang and has published in prestigious journals such as Annals of Oncology, Annals of the Rheumatic Diseases and Journal of Affective Disorders.

In The Last Decade

Fangyuan Hu

37 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangyuan Hu China 16 367 164 144 136 80 40 765
Fang Wu China 21 230 0.6× 421 2.6× 147 1.0× 85 0.6× 57 0.7× 67 1.0k
Laure-Anne Teuwen Belgium 9 178 0.5× 267 1.6× 129 0.9× 118 0.9× 76 0.9× 25 1.1k
Colin F. Spraggs United Kingdom 17 301 0.8× 430 2.6× 63 0.4× 289 2.1× 67 0.8× 48 1.1k
Satoshi Takakura Japan 18 291 0.8× 445 2.7× 211 1.5× 112 0.8× 43 0.5× 37 1.1k
Laure Thomas France 15 113 0.3× 131 0.8× 143 1.0× 64 0.5× 225 2.8× 28 1.6k
Lucy Oldfield United Kingdom 9 308 0.8× 188 1.1× 59 0.4× 59 0.4× 42 0.5× 17 759
Folefac Aminkeng Singapore 14 194 0.5× 202 1.2× 92 0.6× 71 0.5× 39 0.5× 26 689
Jacek Daroszewski Poland 17 160 0.4× 198 1.2× 78 0.5× 52 0.4× 71 0.9× 54 937
Yohannes T. Ghebre United States 14 125 0.3× 288 1.8× 73 0.5× 374 2.8× 58 0.7× 21 954
Vibeke Krüse Belgium 18 675 1.8× 312 1.9× 303 2.1× 240 1.8× 89 1.1× 48 1.2k

Countries citing papers authored by Fangyuan Hu

Since Specialization
Citations

This map shows the geographic impact of Fangyuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyuan Hu more than expected).

Fields of papers citing papers by Fangyuan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyuan Hu. The network helps show where Fangyuan Hu may publish in the future.

Co-authorship network of co-authors of Fangyuan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyuan Hu. A scholar is included among the top collaborators of Fangyuan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyuan Hu. Fangyuan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhai, Yinghong, Xiaofei Ye, Wentao Shi, et al.. (2024). Neurotoxicity associated with chimeric antigen receptor T-cell therapy: a real-world study leveraging the FDA Adverse Event Reporting System. Expert Opinion on Drug Safety. 25(1). 157–165.
2.
Zhai, Yinghong, Fangyuan Hu, Yuan Lei, et al.. (2024). Atrial fibrillation increases the risk of all-cause dementia, Alzheimer's disease, and vascular dementia: A cohort study of 373, 415 participants in the UK Biobank. Journal of Affective Disorders. 351. 323–330. 6 indexed citations
3.
4.
Hu, Fangyuan, Yinghong Zhai, Xia Ye, et al.. (2023). Ocular Toxicities in Chimeric Antigen Receptor T-Cell Therapy: A Real-World Study Leveraging FAERS Database. Immunotherapy. 16(3). 161–172. 2 indexed citations
5.
Hu, Fangyuan, et al.. (2023). Probing the Internal Physics of Neutron Stars through the Observed Braking Indices and Magnetic Tilt Angles of Several Young Pulsars. Research in Astronomy and Astrophysics. 23(5). 55020–55020. 3 indexed citations
6.
Zheng, Xinyu, Rui Su, Fangyuan Hu, et al.. (2022). Low-dose IL-2 therapy restores imbalance between Th17 and regulatory T cells in patients with the dermatomyositis combined with EBV/CMV viremia. Autoimmunity Reviews. 21(11). 103186–103186. 11 indexed citations
7.
Zhai, Yinghong, Xiaofei Ye, Fangyuan Hu, et al.. (2022). Metabolic and Nutritional Disorders Following the Administration of Immune Checkpoint Inhibitors: A Pharmacovigilance Study. Frontiers in Endocrinology. 12. 809063–809063. 2 indexed citations
8.
Wang, Yanyan, Rui Su, Qiaoling Guo, et al.. (2021). Reduction of peripheral regulatory T cells in active rheumatoid arthritis patients with coronary artery disease. BMC Immunology. 22(1). 76–76. 9 indexed citations
9.
Hu, Fangyuan, Jia Wang, Sheng‐Xiao Zhang, et al.. (2021). Absolute reduction of peripheral regulatory T cell in patients with relapsing polychondritis. Clinical and Experimental Rheumatology. 39(3). 487–493. 7 indexed citations
10.
Ye, Xiaofei, Xiaojing Guo, Dongxu Liu, et al.. (2021). Safety of SGLT2 Inhibitors: A Pharmacovigilance Study from 2013 to 2021 Based on FAERS. Frontiers in Pharmacology. 12. 766125–766125. 30 indexed citations
11.
Zhang, Sheng‐Xiao, Jia Wang, Caihong Wang, et al.. (2021). Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211011370–1759720X211011370. 23 indexed citations
12.
Sun, Yubo, Mo Liu, Xinsheng Fan, et al.. (2021). Effects of cigarette smoke on the aggravation of ovalbumin-induced asthma and the expressions of TRPA1 and tight junctions in mice. Molecular Immunology. 135. 62–72. 16 indexed citations
13.
Zhai, Yinghong, Xiaofei Ye, Fangyuan Hu, et al.. (2021). Cardiovascular Toxicity of Carfilzomib: The Real-World Evidence Based on the Adverse Event Reporting System Database of the FDA, the United States. Frontiers in Cardiovascular Medicine. 8. 735466–735466. 28 indexed citations
14.
Li, Mengwen, et al.. (2020). The neuro-immune interaction in airway inflammation through TRPA1 expression in CD4+ T cells of asthmatic mice. International Immunopharmacology. 86. 106696–106696. 20 indexed citations
15.
Zhai, Yinghong, Xiaofei Ye, Fangyuan Hu, et al.. (2019). Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. Journal for ImmunoTherapy of Cancer. 7(1). 286–286. 128 indexed citations
16.
Osta, Badi El, et al.. (2017). Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials. Critical Reviews in Oncology/Hematology. 119. 1–12. 146 indexed citations
17.
Osta, Badi El, et al.. (2016). A meta-analysis of immune-related adverse events (irAE) of immune checkpoint inhibitors (ICI) from cancer clinical trials. Annals of Oncology. 27. vi369–vi369. 8 indexed citations
18.
Chen, Xi, et al.. (2016). Multi-resolution elongated CS-LDP with Gabor feature for face recognition. International Journal of Biometrics. 8(1). 19–19. 1 indexed citations
19.
Luo, Qin, Cun Wang, Guang‐Zhi Jin, et al.. (2015). LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway. Carcinogenesis. 36(10). 1201–1212. 58 indexed citations
20.
Wang, Cun, Guang‐Zhi Jin, Haojie Jin, et al.. (2014). Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma. Oncotarget. 6(5). 2903–2916. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fang Wu Breakdown of academic impact, for papers by Laure-Anne Teuwen Breakdown of academic impact, for papers by Colin F. Spraggs Breakdown of academic impact, for papers by Satoshi Takakura Breakdown of academic impact, for papers by Laure Thomas Breakdown of academic impact, for papers by Lucy Oldfield Breakdown of academic impact, for papers by Folefac Aminkeng Breakdown of academic impact, for papers by Jacek Daroszewski Breakdown of academic impact, for papers by Yohannes T. Ghebre Breakdown of academic impact, for papers by Vibeke Krüse
Rankless by CCL
2026